|
US2004228910A1
|
|
Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
|
|
US2005019268A1
|
|
Spray containing ubiquinone Qn
|
|
US2004034107A1
|
|
Ubiquinone Qn for the treatment of pain
|
|
AU2003218718A8
|
|
Utilization of ubiquinones for influencing the effect of histamine
|
|
DE19905880A1
|
|
Spray containing ubiquinone Qn
|
|
DE19905879A1
|
|
Ubiquinon Qn used to treat pain
|
|
US6228891B1
|
|
Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
|
|
US6255354B1
|
|
Preparation of a pulmonary surfactant for instillation and oral application
|
|
EP1398026A2
|
|
The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone in the treatment of incontinence
|
|
EP1007021A1
|
|
Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
|
|
DE19705230C1
|
|
Pulmonary surfactant preparation for instillation and oral use
|
